Nicolet Advisory Services LLC Buys 233 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Nicolet Advisory Services LLC increased its stake in HealthEquity, Inc. (NASDAQ:HQY) by 5.8% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 4,218 shares of the company’s stock after acquiring an additional 233 shares during the period. Nicolet Advisory Services LLC’s holdings in HealthEquity were worth $330,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Clearbridge Investments LLC raised its stake in shares of HealthEquity by 1.9% during the second quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock worth $204,915,000 after buying an additional 43,491 shares during the last quarter. Mackenzie Financial Corp lifted its stake in shares of HealthEquity by 16.0% in the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after purchasing an additional 325,906 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of HealthEquity by 8.1% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,547,402 shares of the company’s stock worth $133,377,000 after purchasing an additional 115,841 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of HealthEquity by 0.8% during the second quarter. Allspring Global Investments Holdings LLC now owns 1,122,057 shares of the company’s stock worth $96,721,000 after purchasing an additional 9,125 shares during the period. Finally, Janus Henderson Group PLC increased its holdings in HealthEquity by 1.1% in the first quarter. Janus Henderson Group PLC now owns 1,100,715 shares of the company’s stock valued at $89,851,000 after purchasing an additional 12,448 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Trading Down 0.4 %

NASDAQ HQY opened at $104.25 on Monday. The stock’s 50 day moving average price is $87.74 and its two-hundred day moving average price is $81.95. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. The stock has a market capitalization of $9.10 billion, a price-to-earnings ratio of 86.88, a PEG ratio of 1.64 and a beta of 0.52. HealthEquity, Inc. has a 52 week low of $62.10 and a 52 week high of $105.73.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.16. The firm had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. As a group, analysts anticipate that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now owns 54,719 shares in the company, valued at $4,540,582.62. This represents a 13.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Frank Corvino sold 1,247 shares of HealthEquity stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total value of $100,084.22. Following the transaction, the director now owns 4,823 shares of the company’s stock, valued at $387,093.98. This represents a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 10,536 shares of company stock worth $884,517 over the last quarter. 2.20% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of recent analyst reports. The Goldman Sachs Group began coverage on HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price on the stock. Royal Bank of Canada restated an “outperform” rating and set a $92.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. BTIG Research increased their target price on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Bank of America lifted their price target on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $107.23.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.